CTRI/2011/07/001860已完成未知
A randomized controlled trial of terlipressin and albumin versus albumin, low dose dopamine and frusemide in hepatorenal syndrome
il0 个研究点目标入组 80 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 80
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •All patients with cirrhosis and HRS as defined by International ascites club diagnostic criteria
排除标准
- •Active GI bleed, Presence of sepsis or hypotension requiring inotropic support, Known underlying pre-existing primary renal disease, Ischemic heart disease, Hepatocellular carcinoma, Diabetes mellitus, Portal vein thrombosis, HVOTO, Tubercular peritonitis, Lack of informed consent
研究者
相似试验
已完成
不适用
A controlled trial of terlipressin plus banding ligation versus terlipressin alone in the management of acute esophageal variceal bleedingAcute oesophageal variceal bleeding but stopped bleeding during emergency endoscopyNutritional, Metabolic, EndocrineOesophageal varicesISRCTN28353453Republic of China National Science Council (Taiwan)120
已完成
3 期
Study of Terlipressin Versus Placebo to Treat Hepatorenal Syndrome Type 1Hepatorenal SyndromeNCT00089570Mallinckrodt112
尚未招募
2 期
Comparison of Terlipressin and low dose Terlipressin and noradrenalin in HRS-AKI patients of ACLFCTRI/2023/10/058546on sponsered
已完成
不适用
Effects of Terlipressin on Renal Perfusion in Patients With Septic ShockSeptic ShockNCT04948372Southeast University, China22
已完成
3 期
A Placebo-Controlled, Double-Blind Study to Confirm the Reversal of Hepatorenal Syndrome Type 1 With TerlipressinHepatorenal SyndromeNCT01143246Mallinckrodt196